Loading…
Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA
The development of multiple drug resistance in tumor cells is a significant problem in cancer therapy. In human, one of the reasons causing the resistance is due to the overexpression of the mdr1 gene product, P-glycoprotein. In our study, we had developed multiple drug resistant HepG2 cell line (He...
Saved in:
Published in: | Life sciences (1973) 2000-09, Vol.67 (17), p.2117-2124 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c510t-4a4ece5728100b56d7bc11e447be8ef60a119010c27acf15b7e664ed1f5cac153 |
---|---|
cites | |
container_end_page | 2124 |
container_issue | 17 |
container_start_page | 2117 |
container_title | Life sciences (1973) |
container_volume | 67 |
creator | Chan, Judy Yuet-Wa Chu, Andrew Chi-Yuen Fung, Kwok-Pui |
description | The development of multiple drug resistance in tumor cells is a significant problem in cancer therapy. In human, one of the reasons causing the resistance is due to the overexpression of the mdr1 gene product, P-glycoprotein. In our study, we had developed multiple drug resistant HepG2 cell line (HepG2/DR). To reverse the resistance, HepG2-DR cells were treated with antisense RNA against mdr1 gene. Total RNA and protein were extracted from the transfected cells. Northern analysis showed that mRNA level of mdr1 was decreased whereas a reduction in P-glycoprotein was detected by Western blot. By using flow cytometry, the ability of intracellular doxorubicin retention increased and drug efflux decreased in the treated cells. The result also showed that the cellular sensitivity to doxorubicin, vincristine and methotrexate measured in IC
50 increased 83.3% 84.6% and 50% respectively. All these findings suggested that the expression of p-glycoprotein was successfully inhibited by antisense RNA and the drug resistance was reduced. |
doi_str_mv | 10.1016/S0024-3205(00)00798-0 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17643494</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0024320500007980</els_id><sourcerecordid>17643494</sourcerecordid><originalsourceid>FETCH-LOGICAL-c510t-4a4ece5728100b56d7bc11e447be8ef60a119010c27acf15b7e664ed1f5cac153</originalsourceid><addsrcrecordid>eNqFkc9O3DAQxi3UCraUR6DyqYJD6Exix7unCiEKSKit-udsOc5k11XipLaD2Cfp6zZhVyD10pOl8e-bb2Y-xk4RLhCw_PAdIBdZkYM8AzgHUKtlBgdsgUu1yqAs8BVbPCNH7E2MvwBASlUcsiNEkEqVuGB_7vzGVS653vO-4V-zdbu1_RD6RM5zehwCxTh_Gl_zQA8Uomlnsg7jeipEF5PxlubSZuyM5xsaTOo7w29puMm5pbaNvNrybmyT-1e1Jk_8rKsDnk8OyUXykfi3z5dv2evGtJFO9u8x-_np-sfVbXb_5ebu6vI-sxIhZcIIsiRVvkSASpa1qiwiCaEqWlJTgkFcAYLNlbENykpRWQqqsZHWWJTFMXu_6zut_HukmHTn4jyz8dSPUaMqRSFWYgLlDrShjzFQo4fgOhO2GkHPieinRPR8bg2gnxLRMOne7Q3GqqP6RbWPYAI-7gCa1nxwFHS0jqbj1C6QTbru3X8s_gLcXp0d</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17643494</pqid></control><display><type>article</type><title>Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA</title><source>ScienceDirect Freedom Collection</source><creator>Chan, Judy Yuet-Wa ; Chu, Andrew Chi-Yuen ; Fung, Kwok-Pui</creator><creatorcontrib>Chan, Judy Yuet-Wa ; Chu, Andrew Chi-Yuen ; Fung, Kwok-Pui</creatorcontrib><description>The development of multiple drug resistance in tumor cells is a significant problem in cancer therapy. In human, one of the reasons causing the resistance is due to the overexpression of the mdr1 gene product, P-glycoprotein. In our study, we had developed multiple drug resistant HepG2 cell line (HepG2/DR). To reverse the resistance, HepG2-DR cells were treated with antisense RNA against mdr1 gene. Total RNA and protein were extracted from the transfected cells. Northern analysis showed that mRNA level of mdr1 was decreased whereas a reduction in P-glycoprotein was detected by Western blot. By using flow cytometry, the ability of intracellular doxorubicin retention increased and drug efflux decreased in the treated cells. The result also showed that the cellular sensitivity to doxorubicin, vincristine and methotrexate measured in IC
50 increased 83.3% 84.6% and 50% respectively. All these findings suggested that the expression of p-glycoprotein was successfully inhibited by antisense RNA and the drug resistance was reduced.</description><identifier>ISSN: 0024-3205</identifier><identifier>EISSN: 1879-0631</identifier><identifier>DOI: 10.1016/S0024-3205(00)00798-0</identifier><identifier>PMID: 11057761</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Antineoplastic Agents - pharmacokinetics ; Antineoplastic Agents - toxicity ; Antisense nucleic acid ; ATP Binding Cassette Transporter, Subfamily B, Member 1 - drug effects ; ATP Binding Cassette Transporter, Subfamily B, Member 1 - genetics ; Carcinoma, Hepatocellular ; Cell Survival - drug effects ; Cloning, Molecular ; doxorubicin ; Doxorubicin - pharmacokinetics ; Doxorubicin - toxicity ; Drug Resistance, Multiple - genetics ; Gene Expression Regulation, Neoplastic - drug effects ; Gene Expression Regulation, Neoplastic - physiology ; Humans ; Liver Neoplasms ; mdr1 gene ; methotrexate ; Methotrexate - pharmacokinetics ; Methotrexate - toxicity ; Multiple drug resistance ; P-glycoprotein ; RNA, Antisense - genetics ; RNA, Antisense - pharmacology ; Transcription, Genetic - drug effects ; Transfection - methods ; Tumor Cells, Cultured ; vincristine ; Vincristine - pharmacokinetics ; Vincristine - toxicity</subject><ispartof>Life sciences (1973), 2000-09, Vol.67 (17), p.2117-2124</ispartof><rights>2000 Elsevier Science Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c510t-4a4ece5728100b56d7bc11e447be8ef60a119010c27acf15b7e664ed1f5cac153</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11057761$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chan, Judy Yuet-Wa</creatorcontrib><creatorcontrib>Chu, Andrew Chi-Yuen</creatorcontrib><creatorcontrib>Fung, Kwok-Pui</creatorcontrib><title>Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA</title><title>Life sciences (1973)</title><addtitle>Life Sci</addtitle><description>The development of multiple drug resistance in tumor cells is a significant problem in cancer therapy. In human, one of the reasons causing the resistance is due to the overexpression of the mdr1 gene product, P-glycoprotein. In our study, we had developed multiple drug resistant HepG2 cell line (HepG2/DR). To reverse the resistance, HepG2-DR cells were treated with antisense RNA against mdr1 gene. Total RNA and protein were extracted from the transfected cells. Northern analysis showed that mRNA level of mdr1 was decreased whereas a reduction in P-glycoprotein was detected by Western blot. By using flow cytometry, the ability of intracellular doxorubicin retention increased and drug efflux decreased in the treated cells. The result also showed that the cellular sensitivity to doxorubicin, vincristine and methotrexate measured in IC
50 increased 83.3% 84.6% and 50% respectively. All these findings suggested that the expression of p-glycoprotein was successfully inhibited by antisense RNA and the drug resistance was reduced.</description><subject>Antineoplastic Agents - pharmacokinetics</subject><subject>Antineoplastic Agents - toxicity</subject><subject>Antisense nucleic acid</subject><subject>ATP Binding Cassette Transporter, Subfamily B, Member 1 - drug effects</subject><subject>ATP Binding Cassette Transporter, Subfamily B, Member 1 - genetics</subject><subject>Carcinoma, Hepatocellular</subject><subject>Cell Survival - drug effects</subject><subject>Cloning, Molecular</subject><subject>doxorubicin</subject><subject>Doxorubicin - pharmacokinetics</subject><subject>Doxorubicin - toxicity</subject><subject>Drug Resistance, Multiple - genetics</subject><subject>Gene Expression Regulation, Neoplastic - drug effects</subject><subject>Gene Expression Regulation, Neoplastic - physiology</subject><subject>Humans</subject><subject>Liver Neoplasms</subject><subject>mdr1 gene</subject><subject>methotrexate</subject><subject>Methotrexate - pharmacokinetics</subject><subject>Methotrexate - toxicity</subject><subject>Multiple drug resistance</subject><subject>P-glycoprotein</subject><subject>RNA, Antisense - genetics</subject><subject>RNA, Antisense - pharmacology</subject><subject>Transcription, Genetic - drug effects</subject><subject>Transfection - methods</subject><subject>Tumor Cells, Cultured</subject><subject>vincristine</subject><subject>Vincristine - pharmacokinetics</subject><subject>Vincristine - toxicity</subject><issn>0024-3205</issn><issn>1879-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNqFkc9O3DAQxi3UCraUR6DyqYJD6Exix7unCiEKSKit-udsOc5k11XipLaD2Cfp6zZhVyD10pOl8e-bb2Y-xk4RLhCw_PAdIBdZkYM8AzgHUKtlBgdsgUu1yqAs8BVbPCNH7E2MvwBASlUcsiNEkEqVuGB_7vzGVS653vO-4V-zdbu1_RD6RM5zehwCxTh_Gl_zQA8Uomlnsg7jeipEF5PxlubSZuyM5xsaTOo7w29puMm5pbaNvNrybmyT-1e1Jk_8rKsDnk8OyUXykfi3z5dv2evGtJFO9u8x-_np-sfVbXb_5ebu6vI-sxIhZcIIsiRVvkSASpa1qiwiCaEqWlJTgkFcAYLNlbENykpRWQqqsZHWWJTFMXu_6zut_HukmHTn4jyz8dSPUaMqRSFWYgLlDrShjzFQo4fgOhO2GkHPieinRPR8bg2gnxLRMOne7Q3GqqP6RbWPYAI-7gCa1nxwFHS0jqbj1C6QTbru3X8s_gLcXp0d</recordid><startdate>20000915</startdate><enddate>20000915</enddate><creator>Chan, Judy Yuet-Wa</creator><creator>Chu, Andrew Chi-Yuen</creator><creator>Fung, Kwok-Pui</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope></search><sort><creationdate>20000915</creationdate><title>Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA</title><author>Chan, Judy Yuet-Wa ; Chu, Andrew Chi-Yuen ; Fung, Kwok-Pui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c510t-4a4ece5728100b56d7bc11e447be8ef60a119010c27acf15b7e664ed1f5cac153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Antineoplastic Agents - pharmacokinetics</topic><topic>Antineoplastic Agents - toxicity</topic><topic>Antisense nucleic acid</topic><topic>ATP Binding Cassette Transporter, Subfamily B, Member 1 - drug effects</topic><topic>ATP Binding Cassette Transporter, Subfamily B, Member 1 - genetics</topic><topic>Carcinoma, Hepatocellular</topic><topic>Cell Survival - drug effects</topic><topic>Cloning, Molecular</topic><topic>doxorubicin</topic><topic>Doxorubicin - pharmacokinetics</topic><topic>Doxorubicin - toxicity</topic><topic>Drug Resistance, Multiple - genetics</topic><topic>Gene Expression Regulation, Neoplastic - drug effects</topic><topic>Gene Expression Regulation, Neoplastic - physiology</topic><topic>Humans</topic><topic>Liver Neoplasms</topic><topic>mdr1 gene</topic><topic>methotrexate</topic><topic>Methotrexate - pharmacokinetics</topic><topic>Methotrexate - toxicity</topic><topic>Multiple drug resistance</topic><topic>P-glycoprotein</topic><topic>RNA, Antisense - genetics</topic><topic>RNA, Antisense - pharmacology</topic><topic>Transcription, Genetic - drug effects</topic><topic>Transfection - methods</topic><topic>Tumor Cells, Cultured</topic><topic>vincristine</topic><topic>Vincristine - pharmacokinetics</topic><topic>Vincristine - toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chan, Judy Yuet-Wa</creatorcontrib><creatorcontrib>Chu, Andrew Chi-Yuen</creatorcontrib><creatorcontrib>Fung, Kwok-Pui</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><jtitle>Life sciences (1973)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chan, Judy Yuet-Wa</au><au>Chu, Andrew Chi-Yuen</au><au>Fung, Kwok-Pui</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA</atitle><jtitle>Life sciences (1973)</jtitle><addtitle>Life Sci</addtitle><date>2000-09-15</date><risdate>2000</risdate><volume>67</volume><issue>17</issue><spage>2117</spage><epage>2124</epage><pages>2117-2124</pages><issn>0024-3205</issn><eissn>1879-0631</eissn><abstract>The development of multiple drug resistance in tumor cells is a significant problem in cancer therapy. In human, one of the reasons causing the resistance is due to the overexpression of the mdr1 gene product, P-glycoprotein. In our study, we had developed multiple drug resistant HepG2 cell line (HepG2/DR). To reverse the resistance, HepG2-DR cells were treated with antisense RNA against mdr1 gene. Total RNA and protein were extracted from the transfected cells. Northern analysis showed that mRNA level of mdr1 was decreased whereas a reduction in P-glycoprotein was detected by Western blot. By using flow cytometry, the ability of intracellular doxorubicin retention increased and drug efflux decreased in the treated cells. The result also showed that the cellular sensitivity to doxorubicin, vincristine and methotrexate measured in IC
50 increased 83.3% 84.6% and 50% respectively. All these findings suggested that the expression of p-glycoprotein was successfully inhibited by antisense RNA and the drug resistance was reduced.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>11057761</pmid><doi>10.1016/S0024-3205(00)00798-0</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0024-3205 |
ispartof | Life sciences (1973), 2000-09, Vol.67 (17), p.2117-2124 |
issn | 0024-3205 1879-0631 |
language | eng |
recordid | cdi_proquest_miscellaneous_17643494 |
source | ScienceDirect Freedom Collection |
subjects | Antineoplastic Agents - pharmacokinetics Antineoplastic Agents - toxicity Antisense nucleic acid ATP Binding Cassette Transporter, Subfamily B, Member 1 - drug effects ATP Binding Cassette Transporter, Subfamily B, Member 1 - genetics Carcinoma, Hepatocellular Cell Survival - drug effects Cloning, Molecular doxorubicin Doxorubicin - pharmacokinetics Doxorubicin - toxicity Drug Resistance, Multiple - genetics Gene Expression Regulation, Neoplastic - drug effects Gene Expression Regulation, Neoplastic - physiology Humans Liver Neoplasms mdr1 gene methotrexate Methotrexate - pharmacokinetics Methotrexate - toxicity Multiple drug resistance P-glycoprotein RNA, Antisense - genetics RNA, Antisense - pharmacology Transcription, Genetic - drug effects Transfection - methods Tumor Cells, Cultured vincristine Vincristine - pharmacokinetics Vincristine - toxicity |
title | Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T19%3A05%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20P-glycoprotein%20expression%20and%20reversal%20of%20drug%20resistance%20of%20human%20hepatoma%20HepG2%20cells%20by%20multidrug%20resistance%20gene%20(mdr1)%20antisense%20RNA&rft.jtitle=Life%20sciences%20(1973)&rft.au=Chan,%20Judy%20Yuet-Wa&rft.date=2000-09-15&rft.volume=67&rft.issue=17&rft.spage=2117&rft.epage=2124&rft.pages=2117-2124&rft.issn=0024-3205&rft.eissn=1879-0631&rft_id=info:doi/10.1016/S0024-3205(00)00798-0&rft_dat=%3Cproquest_cross%3E17643494%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c510t-4a4ece5728100b56d7bc11e447be8ef60a119010c27acf15b7e664ed1f5cac153%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17643494&rft_id=info:pmid/11057761&rfr_iscdi=true |